← GILEAD SCIENCES, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $13.5b
$4.6b -65.72%
$5.5b +17.87%
$5.4b -1.26%
$123.0m -97.72%
$6.2b +4960.98%
$4.6b -26.23%
$5.7b +23.37%
$480.0m -91.53%
$8.5b +1672.92%
—
Net Income (Loss) Attributable to Noncontrolling Interest ($13.0m) $16.0m $5.0m ($22.0m) ($34.0m) ($24.0m) ($26.0m) ($52.0m) $0 $0 —
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $13.5b $4.6b $5.5b $5.4b $89.0m $6.2b $4.6b $5.6b $480.0m $8.5b —
Amortization $981.0m $1.1b $1.2b $1.1b $1.2b $1.7b $1.8b $2.3b $2.4b $2.4b $2.4b
Amortization of Intangible Assets — — — — — — $1.8b $2.3b $2.4b $2.4b —
Depreciation $177.0m $233.0m $226.0m $255.0m $288.0m $329.0m $323.0m $354.0m $381.0m $370.0m $371.0m
Deferred Income Tax Expense (Benefit) ($119.0m) ($82.0m) $289.0m ($2.1b) ($214.0m) ($116.0m) ($1.6b) ($962.0m) ($1.8b) $160.0m $129.0m
Share-based Payment Arrangement, Expense $380.0m $649.0m $845.0m $636.0m $1.1b $635.0m $645.0m $796.0m $969.0m $894.0m $909.0m
Share-based Payment Arrangement, Noncash Expense $380.0m $638.0m $845.0m $636.0m $643.0m $635.0m $637.0m $766.0m $835.0m $894.0m $909.0m
Stock-based compensation expense $380.0m $638.0m $845.0m $636.0m $643.0m $635.0m $637.0m $766.0m $835.0m $894.0m $909.0m
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $432.0m $0 $820.0m $800.0m $0 $0 $2.7b $50.0m $4.2b $590.0m —
In-process research and development impairments $432.0m $0 $820.0m $800.0m $0 $0 $2.7b $50.0m $4.2b $590.0m —
Nonoperating Income (Expense) $428.0m $523.0m $676.0m $1.9b ($1.4b) ($639.0m) ($581.0m) $198.0m $6.0m $798.0m —
Other Nonoperating Income (Expense) — — — — — — — — ($2.0m) ($1.0m) —
Changes in operating assets and liabilities:
Accounts receivable, net $1.2b $754.0m $480.0m ($218.0m) ($1.2b) $313.0m ($406.0m) $157.0m $139.0m ($367.0m) ($353.0m)
Increase (Decrease) in Accounts Receivable ($1.2b) ($754.0m) ($480.0m) $218.0m $1.2b ($313.0m) $406.0m ($157.0m) ($139.0m) $367.0m ($353.0m)
Increase (Decrease) in Inventories $488.0m $253.0m $310.0m $95.0m $195.0m ($11.0m) $310.0m $842.0m $426.0m $1.0b ($835.0m)
Inventories ($488.0m) ($253.0m) ($310.0m) ($95.0m) ($195.0m) $11.0m ($310.0m) ($842.0m) ($426.0m) ($1.0b) ($835.0m)
Inventory Write-down — — $572.0m $649.0m — $228.0m — — — — —
Accounts payable $47.0m ($430.0m) ($39.0m) ($61.0m) $80.0m ($118.0m) $226.0m ($347.0m) $290.0m ($132.0m) $86.0m
Accrued and other liabilities $425.0m ($818.0m) ($514.0m) ($389.0m) $640.0m $689.0m ($775.0m) $458.0m $108.0m $6.0m —
Net Cash Provided by (Used in) Operating Activities $16.7b
$11.9b -28.62%
$8.4b -29.40%
$9.1b +8.86%
$8.2b -10.67%
$11.4b +39.37%
$9.1b -20.31%
$8.0b -11.75%
$10.8b +35.25%
$10.0b -7.47%
$13.6b +35.24%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $748.0m $590.0m $924.0m $825.0m $650.0m $579.0m $728.0m $585.0m $523.0m $563.0m ($609.0m)
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $1.7b $7.8b $24.3b $22.4b $9.5b $2.2b $1.6b $1.3b $327.0m $55.0m —
Proceeds from maturities of marketable debt securities $1.7b $7.8b $24.3b $22.4b $9.5b $2.2b $1.6b $1.3b $327.0m $55.0m —
Proceeds from sales of marketable debt securities — $10.4b $1.5b $7.5b $23.2b $730.0m $412.0m $510.0m $2.3b $854.0m —
Purchases of marketable debt securities — ($23.3b) ($10.2b) ($30.5b) ($20.3b) ($3.5b) ($1.8b) ($1.9b) ($244.0m) ($3.9b) —
Acquisitions, including in-process research and development, net of cash acquired $0 ($10.4b) $0 $0 ($25.7b) ($1.4b) ($1.8b) ($1.2b) ($4.8b) ($1.1b) —
Payments to Acquire Businesses, Net of Cash Acquired — $10.4b $0 $0 $25.7b $1.4b $1.8b $1.2b $4.8b $1.1b ($12.1b)
Other investing activities, net — $0 ($190.0m) ($384.0m) ($171.0m) ($163.0m) ($1.0m) ($1.0m) $58.0m $2.0m —
Payments for (Proceeds from) Other Investing Activities — — — $384.0m $171.0m $163.0m $1.0m $1.0m ($58.0m) ($2.0m) —
Net Cash Provided by (Used in) Investing Activities ($12.0b) ($16.1b) $14.4b ($7.8b) ($14.6b) ($3.1b) ($2.5b) ($2.3b) ($3.4b) ($4.8b) ($10.8b)
Cash flows from financing activities:
Proceeds from debt financing, net of issuance costs $5.3b $9.0b $0 $0 $8.2b $0 $0 $2.0b $3.5b $0 —
Repayments of Long-term Debt — — — — — $4.8b — — — — ($2.8b)
Repayments of debt and other obligations ($2.0b) ($1.8b) ($6.2b) ($2.8b) ($2.5b) ($4.8b) ($1.5b) ($2.2b) ($2.0b) ($1.8b) ($2.8b)
Payments for Repurchase of Common Stock $11.0b $954.0m $2.9b $1.7b $1.6b $546.0m $1.4b $1.0b $1.1b $1.9b —
Proceeds from Issuance of Common Stock $208.0m $234.0m $289.0m $209.0m $256.0m $169.0m $309.0m $232.0m $422.0m $408.0m $304.0m
Proceeds from issuances of common stock $208.0m $234.0m $289.0m $209.0m $256.0m $169.0m $309.0m $232.0m $422.0m $408.0m —
Repurchases of common stock under repurchase programs ($11.0b) ($954.0m) ($2.9b) ($1.7b) ($1.6b) ($546.0m) ($1.4b) ($1.0b) ($1.1b) ($1.9b) —
Dividends paid $2.5b $2.7b $3.0b $3.2b $3.4b $3.6b $3.7b $3.8b $3.9b $4.0b ($4.1b)
Payments of dividends ($2k) ($3k) ($3k) ($3k) ($3k) ($4k) ($4k) ($4k) ($4k) ($4k) ($4.1b)
Other financing activities, net ($276.0m) ($330.0m) ($486.0m) ($122.0m) ($138.0m) ($145.0m) ($173.0m) ($279.0m) ($281.0m) ($440.0m) —
Proceeds from (Payments for) Other Financing Activities — ($330.0m) ($486.0m) ($122.0m) ($138.0m) ($145.0m) ($173.0m) ($279.0m) ($281.0m) ($440.0m) —
Net Cash Provided by (Used in) Financing Activities ($9.3b)
$3.4b +136.30%
($12.3b) -463.04%
($7.6b) +38.03%
$770.0m +110.09%
($8.9b) -1252.86%
($6.5b) +27.13%
($5.1b) +20.78%
($3.4b) +33.01%
($7.7b) -125.60%
($4.6b) +40.00%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $41.0m $137.0m ($85.0m) ($6.3b) ($5.6b) ($659.0m) $74.0m $673.0m $3.9b ($2.4b) $3.2b
Cash and cash equivalents at beginning of period $12.9b $8.2b $7.6b $11.6b $6.0b $5.3b $5.4b $6.1b $10.0b $7.6b —
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — — $11.6b $6.0b $5.3b $5.4b $6.1b $10.0b $7.6b $3.2b
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $41.0m — ($85.0m) ($2.0m) $43.0m ($35.0m) ($63.0m) $57.0m ($40.0m) $92.0m ($30.0m)
Effect of exchange rate changes on cash and cash equivalents $41.0m $137.0m ($85.0m) ($2.0m) $43.0m ($35.0m) ($63.0m) $57.0m ($40.0m) $92.0m ($30.0m)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Acquired in-process research and development expenses — — $0 $4.3b $5.9b $177.0m $944.0m $1.2b $4.7b $1.0b —
Additional Financial Items
Equity Securities, FV-NI, Gain (Loss) — $0 ($115.0m) ($1.2b) $1.7b $610.0m $657.0m $167.0m ($274.0m) $451.0m —
Equity Securities, FV-NI, Unrealized Gain (Loss) — $0 ($115.0m) ($1.2b) $1.7b $610.0m $657.0m $167.0m $274.0m $404.0m —
Fair Value, Option, Changes in Fair Value, Gain (Loss) ($128.0m) — — — — — — — — — —
Goodwill $1.2b $4.2b $4.1b $4.1b $8.1b $8.3b $8.3b $8.3b $8.3b $8.3b $2.1b
Income Tax Expense (Benefit) $3.6b $8.9b $2.3b ($204.0m) $1.6b $2.1b $1.2b $1.2b $211.0m $1.3b —
Income Taxes Paid, Net — — — — — — — — — $3.2b —
Income tax assets and liabilities, net — — — — — ($361.0m) ($364.0m) ($1.8b) ($732.0m) ($2.1b) —
Interest Expense Nonoperating — — — — — — — — $977.0m $1.0b —
Interest Paid, Excluding Capitalized Interest, Operating Activities $885.0m $1.0b $1.1b $982.0m $951.0m $979.0m $907.0m $891.0m $951.0m $1.0b —
Net (gain) loss from equity securities — $0 ($115.0m) ($1.2b) $1.7b $610.0m $657.0m $167.0m $274.0m ($451.0m) —
Net change in cash and cash equivalents ($4.6b) ($641.0m) $10.4b ($6.3b) ($5.6b) ($659.0m) $74.0m $673.0m $3.9b ($2.4b) —
Operating Lease, Expense — — — $162.0m $171.0m $156.0m $162.0m $165.0m $163.0m $169.0m —
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax ($8.0m) ($28.0m) — — — — — — — — —
Other, net $162.0m $304.0m $56.0m $184.0m $250.0m $1.2b $780.0m $826.0m $353.0m $480.0m —
Prepaid expenses and other ($520.0m) $358.0m $903.0m ($307.0m) ($214.0m) ($42.0m) $70.0m $39.0m ($259.0m) ($311.0m) —
Proceeds from (Payments to) Noncontrolling Interests ($90.0m) — — — — — — — — — —
Purchases of equity securities ($357.0m) $0 ($346.0m) ($1.8b) ($455.0m) ($380.0m) ($172.0m) ($442.0m) ($492.0m) ($133.0m) —
Supplemental disclosure of cash flow information:

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.